Authors


Ali Ezzati, MD

Latest:

Addressing the Neurologist Shortage Through Career Opportunities and Supporting Early Investigators: Claire Henchcliffe, MD, DPhil, FANA; Ali Ezzati, MD

A pair of neurologists from the University of California, Irvine, detailed some of the training and career focuses of large federal agencies in effort to address the shortage of neurologists. [WATCH TIME: 4 minutes]


Evanthia Bernitsas, MD

Latest:

Understanding Disadvantages to African Americans in NMOSD Trials: Evanthia Bernitsas, MD

The neurologist at Wayne State University provided background on why there needs to be a continued focus on including and studying African American patients with NMOSD in trials. [WATCH TIME 3 minutes]


E. Ann Yeh, MD

Latest:

Treatment and Diagnosis of MOG-Associated Disorders in Pediatric vs Adult: E. Ann Yeh, MD

The professor of pediatrics in neurology at the University of Toronto discussed differences in disease course, treatment strategy, and trial challenges of MOG-associated disorders in pediatric versus adult patients. [WATCH TIME: 5 minutes]


Jessica Nickrand, PhD

Latest:

Insights From the Child Neurology Foundation: Enhancing Pediatric Epilepsy Care Through Holistic Collaboration

Jessica Nickrand, PhD, and Allyson Eyermann from the Child Neurology Foundation emphasized the importance of multidisciplinary collaboration for children with epilepsy and their families.


Marcello Paglione, PhD

Latest:

Givinostat's Multifactorial Mechanism of Action in Duchenne Muscular Dystrophy: Marcello Paglione, PhD

The executive medical lead at Italfarmaco SpA expressed his confidence in givinostat to mitigate the progression of Duchenne muscular dystrophy, emphasizing its multifactorial mechanism of action. [WATCH TIME: 5 minutes]


Elizabeth Cassidy, MPH

Latest:

Gaining Greater Insights Into Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders: Elizabeth M. Cassidy, MPH

The research project manager at the TSC Alliance provided additional clarity into a new study presented at AES 2023 assessing the links between TSC-associated neuropsychiatric disorders and seizure duration. [WATCH TIME: 4 minutes]


Min Lou MD, PhD

Latest:

Expanding the Time Window for Intravenous Thrombolysis in Ischemic Stroke: Min Lou MD, PhD

The professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine discussed findings from a trial suggesting that intravenous thrombolysis could benefit patients with ischemic stroke up to 24 hours after symptom onset. [WATCH TIME: 8 minutes]


Deborah L. Benzil, MD, FAANS

Latest:

Finding Happiness as a Trailblazer

Deborah Benzil, MD, FAAS, vice chair of neurosurgery at Cleveland Clinic's Center for Spine Health, shared her extraordinary journey of resilience, from overcoming repeated rejections to becoming a trailblazer for women in neurosurgery, and reflects on the progress made and the challenges that remain.


Taylor Gonyou, DO

Latest:

Gauging MS Disease Activity Through Octave’s MSDA Test: Taylor Gonyou, DO

The multiple sclerosis fellow at Michigan Institute for Neurologic Disorders provided perspective on the clinical utility and advantages of a multi-protein test that assesses multiple sclerosis disease activity. [WATCH TIME: 3 minutes]



Rachel Horne

Latest:

Hiding in Plain Sight: MS and Domestic Violence and Abuse

When looking at the intersection of MS and domestic abuse, one can find hidden challenges and a need for innovative efforts to support vulnerable patients and survivors.


Rachel Brandstadter, MD

Latest:

Pregnancy and Family Planning Considerations When Treating Patients With Multiple Sclerosis

In this episode of MEDcast, Dr Krieger, Dr Brandstadter, and Dr Bove discuss MS care in patients who are considering pregnancy. They highlight treatment options, monitoring recommendations during and after pregnancy, as well as other crucial considerations when caring for patients with childbearing goals.


Margherita Carboni, PhD

Latest:

Using Biomarker Testing to Advance Alzheimer Diagnostics: Margherita Carboni, PhD

The indication lead of neurology at Roche Diagnostics International talked about the latest Alzheimer biomarkers that are aimed to transform diagnostic accuracy and accessibility as well as enhance early detection and treatment. [WATCH TIME: 5 minutes]


Prashanth Rajarajan, MD, PhD

Latest:

Safety of Cancer Treatments in Patients With Multiple Sclerosis: Prashanth Rajarajan, MD, PhD

The neurology resident at Massachusetts General Brigham talked about assessing the safety of cancer treatments in patients with multiple sclerosis using checkpoint inhibitors. [WATCH TIME: 6 minutes]


Robert K. Shin, MD

Latest:

The State of Multiple Sclerosis Therapy and Trends in Thinking: Robert K. Shin, MD

The professor of neurology at MedStar Georgetown University Hospital shared his perspective on the trends in thinking about the treatment of MS and how an improved understanding of underlying processes has led to a shift in the field. [WATCH TIME: 5 minutes]


Robert Griggs, MD

Latest:

Ethical Values and Principals in Neurology Departments, Medical School

A group of esteemed panelists discussed the important values neurology department directors and educators should prioritize when teaching students of the future. [WATCH TIME: 6 minutes]


Jude Luker, BA (Hons)

Latest:

The Urgent Need for Improved Physician-Patient Conversations on SUDEP: Jude Luker, BA (Hons)

The head of Patient Engagement, Epilepsy and Rare Syndromes (Europe) at UCB Pharma discussed the inconsistencies in educational information given to patients with epilepsy, including the knowns of sudden unexpected death. [WATCH TIME: 4 minutes]


John Morren, MD

Latest:

Building the Myasthenia Gravis Armamentarium

Since it was first discovered in the early 1900s, the therapeutic approaches to treating myasthenia gravis have changed significantly, with several proven treatment options.


Dawn Edhe, PhD

Latest:

State of Mental Health Care for Patients With MS: Dawn Edhe, PhD

The psychologist and professor in the department of rehabilitation medicine at the University of Washington shared her perspective on the state of mental health care in multiple sclerosis. [WATCH TIME: 4 minutes]


Karin Cook

Latest:

Questions of Adherence Raised by Unused Multiple Sclerosis Disease-Modifying Therapies: Darin T. Okuda, MD; Karin Cook

The coauthors of a study assessing costs associated with unused disease-modifying therapies shared their insight into the extended effects of unused treatments in MS, including the importance of transparency between physician and patient. [WATCH TIME: 12 minutes]


Satyanarayana Gedela, MD

Latest:

Advances in Surgical and Neuromodulation Strategies for Epilepsy Management: Satyanarayana Gedela, MD

The division chief of neurology at Nemours Children’s Hospital discussed evolving surgical techniques, neuromodulation therapies, and precision medicine approaches for complex epilepsy cases. [WATCH TIME: 5 minutes}


Renee Shellhaas, MD, MS, FAES

Latest:

Need for Increased Multidisciplinary Study of Newborn and Infant Sleep in Epilepsy: Renee Shellhaas, MD, MS, FAES

The professor of neurology at Washington University School of Medicine in St. Louis spoke about the field of newborn sleep and epilepsy based on a special lecture from the 2022 AES annual meeting. [WATCH TIME: 3 minutes]


Tudor Jovin, MD

Latest:

Highlights of ISC 2024, Trials and Future Innovations for Stroke Care: Tudor Jovin, MD; Lauren Sansing, MD, MS, FAHA

The medical director of the Cooper Neurological Institute and the professor of neurology at Yale University School of Medicine shared a few highlights from research presented at ISC 2024. [WATCH TIME: 7 minutes]


Thomas Wisniewski, MD

Latest:

Exponential Growth of Research, Biomarkers in Alzheimer Disease: Thomas Wisniewski, MD

The director of NYU Langone’s Alzheimer’s Disease Research Center discussed noticeable advancements within the field of Alzheimer disease in recent years and how they contribute to gaining a better understanding of the disease. [WATCH TIME: 5 minutes]


Jonathan R. Isaacson, MD

Latest:

Read All About It: How On-Demand Therapy Has Changed the PD Landscape

As therapeutic development has advanced in Parkinson disease management, the introduction of on-demand options have extended ON time for patients and altered the paradigm of care.


Suraj Muley, MD, FAAN, FACP

Latest:

Clinical Pearls for CIDP Management

Panelists discuss how physicians can improve outcomes for patients with chronic inflammatory demyelinating polyneuropathy (CIDP) by prioritizing early and accurate diagnosis, personalizing treatment plans, regularly monitoring patients, and addressing the psychological and emotional impact of the disease.


J. William Lindsey, MD

Latest:

Exploring Epstein Barr Virus Connection in Multiple Sclerosis Research: J. William Lindsey, MD

The professor in the department of neurology with McGovern Medical School at UTHealth Houston talked about findings from a recent study that investigated T cell specificity in the spinal fluid of patients with multiple sclerosis. [WATCH TIME: 10 minutes]


Jonathan Jagid, MD

Latest:

Continued Evolution of Deep Brain Stimulation in Neurology: Jonathan Jagid, MD; Brian Noga, PhD

A pair of neurologists from the University of Miami Miller School of Medicine provided insight on the various ways deep brain stimulation has changed and the potential treatment opportunities that lie ahead. [WATCH TIME: 4 minutes]


Marcello Moccia, MD, PhD

Latest:

Bridging Clinical Signs and Biological Evidence to Transform MS Diagnosis: Marcello Moccia, MD, PhD

At ECTRIMS 2024, the assistant professor at the University of Naples the latest multiple sclerosis diagnostic criteria, which emphasized a shift toward biologically based diagnoses. [WATCH TIME: 4 minutes]


Ana Krieger, MD, MPH

Latest:

Prioritizing Sleep Health in the Modern World of Sleep Disorders: Ana Krieger, MD, MPH

The medical director of the Center for Sleep Medicine at Weill Cornell Medicine talked about the importance of sleep health in modern life with the increasing prevalence of sleep disorders such as narcolepsy in the United States. [WATCH TIME: 5 minutes]

© 2025 MJH Life Sciences

All rights reserved.